3TR Project: Crossing Disease Borders to Reshape European Research
The 3TR project aims to transform the understanding and treatment of immune-mediated diseases, with its core principles in precision medicine.
At a time when chronic diseases place growing pressure on patients and health systems alike, the 3TR project is rewriting how science is done.
The project is a groundbreaking effort to understand the shared mechanisms driving immune-mediated diseases and to pave the way for truly personalised medicine across Europe.
Backed by €80 million in funding through the Innovative Medicines Initiative (IMI2), 3TR unites 69 organisations across 15 countries.
- Eight major pharmaceutical companies
- Leading academic institutions
This collaboration is one of the largest efforts ever launched in the field of immunology.
3TR follows Europe’s vision of breaking down scientific silos and advancing research that serves the public good.
Author's summary: 3TR project transforms immune-mediated diseases research.
More News
- IndiGo Flights Cancellation Live Updates
- PREDICTED TEAM: How Scorchers will line up for BBL opener
- Benin coup attempt foiled by loyalist troops, interior minister says
- Flight Booking, Cheap Flights, Air Tickets at Lowest Fare
- Cheap Domestic Flights in United States of America
- Benin authorities say coup attempt foiled, President Talon safe
- Tunbridge Wells gridlocked as residents queue for fresh water after five-day outage
- Après la tentative de coup d'Etat au Bénin, la menace du pouvoir kaki plus présente que jamais en Afrique
- GRIDLOCK Definition & Meaning
- Attempted coup d'état in Benin